Core Viewpoint - Quipt Home Medical Corp. has successfully completed a transformative transaction, transitioning to a privately held entity through an arrangement agreement that involved the acquisition of all outstanding common shares for cash consideration of US$3.65 per share [1][2][3] Group 1: Transaction Details - The arrangement was executed under the Business Corporations Act (British Columbia) and involved 1567208 B.C. Ltd. as the purchaser, with funding from Kingswood Capital Management and Forager Capital Management [1][2] - Each outstanding option to acquire shares was deemed unconditionally vested and was surrendered for cash payment based on the difference between the consideration and the exercise price, with options being cancelled if the exercise price was equal to or greater than the consideration [3] - Restricted share units were also cancelled and exchanged for cash payment equal to the consideration [3] Group 2: Company Positioning and Future Outlook - The CEO expressed confidence that the transaction strategically positions the company for long-term success, emphasizing a commitment to clinical excellence and a patient-first approach [3] - Kingswood and Forager partners highlighted their intention to support the company and invest in its growth, aiming to build upon the existing momentum in home-based respiratory care [3] - Following the completion of the arrangement, Quipt's shares will be delisted from NASDAQ and the Toronto Stock Exchange, and the company plans to cease its public reporting obligations in Canada and the U.S. [4] Group 3: Company Overview - Quipt Home Medical Corp. specializes in in-home monitoring and disease management services, focusing on respiratory solutions and chronic disease management for patients in the U.S. healthcare market [7] - The company aims to expand its service offerings to include management of various chronic health conditions, enhancing its role in in-home patient care [7]